Axinn’s representation of Endo Pharmaceuticals Inc. in Sun Pharmaceutical Industries v. Burwell was mentioned in the Bloomberg BNA article, “Ranbaxy Drops Appeal of FDA Actions Revoking Approval of Valcyte, Nexium Copies.”

Click here to read the article. A subscription is required.